Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB14547 | Chloride ion | 1 | Active Not Recruiting | 1 |
DB00515 | Cisplatin | 1 | Active Not Recruiting | 1 |
DB00515 | Cisplatin | 1 | Completed | 1 |
DB00531 | Cyclophosphamide | 1 | Withdrawn | 1 |
DB05643 | IRX-2 | 1 | Withdrawn | 1 |
DB09035 | Nivolumab | 1 | Withdrawn | 1 |
DB06306 | Onalespib | 1 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 1 | Completed | 1 |
DB12257 | Platinum | 1 | Active Not Recruiting | 1 |
DB08875 | Cabozantinib | 2 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 2 | Completed | 1 |
DB14547 | Chloride ion | 2 | Completed | 1 |
DB00515 | Cisplatin | 2 | Completed | 1 |
DB01248 | Docetaxel | 2 | Completed | 1 |
DB00530 | Erlotinib | 2 | Completed | 1 |
DB00331 | Metformin | 2 | Terminated | 1 |
DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
DB01132 | Pioglitazone | 2 | Terminated | 1 |
DB12257 | Platinum | 2 | Completed | 1 |
DB11595 | Atezolizumab | 2 / 3 | Suspended | 1 |
DB00002 | Cetuximab | 2 / 3 | Suspended | 1 |
DB14547 | Chloride ion | 2 / 3 | Suspended | 1 |
DB00515 | Cisplatin | 2 / 3 | Suspended | 1 |
DB01248 | Docetaxel | 2 / 3 | Suspended | 1 |
DB12257 | Platinum | 2 / 3 | Suspended | 1 |